352 related articles for article (PubMed ID: 16127046)
21. Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir.
Quenelle DC; Collins DJ; Wan WB; Beadle JR; Hostetler KY; Kern ER
Antimicrob Agents Chemother; 2004 Feb; 48(2):404-12. PubMed ID: 14742188
[TBL] [Abstract][Full Text] [Related]
22. Comparative study of the anti-human cytomegalovirus activities and toxicities of a tetrahydrofuran phosphonate analogue of guanosine and cidofovir.
Bedard J; May S; Lis M; Tryphonas L; Drach J; Huffman J; Sidwell R; Chan L; Bowlin T; Rando R
Antimicrob Agents Chemother; 1999 Mar; 43(3):557-67. PubMed ID: 10049267
[TBL] [Abstract][Full Text] [Related]
23. A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture.
Cihlar T; Fuller MD; Mulato AS; Cherrington JM
Virology; 1998 Sep; 248(2):382-93. PubMed ID: 9721246
[TBL] [Abstract][Full Text] [Related]
24. Ether lipid ester derivatives of cidofovir inhibit polyomavirus BK replication in vitro.
Randhawa P; Farasati NA; Shapiro R; Hostetler KY
Antimicrob Agents Chemother; 2006 Apr; 50(4):1564-6. PubMed ID: 16569886
[TBL] [Abstract][Full Text] [Related]
25. Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro.
Hartline CB; Gustin KM; Wan WB; Ciesla SL; Beadle JR; Hostetler KY; Kern ER
J Infect Dis; 2005 Feb; 191(3):396-9. PubMed ID: 15633099
[TBL] [Abstract][Full Text] [Related]
26. Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesviruses.
Brideau RJ; Knechtel ML; Huang A; Vaillancourt VA; Vera EE; Oien NL; Hopkins TA; Wieber JL; Wilkinson KF; Rush BD; Schwende FJ; Wathen MW
Antiviral Res; 2002 Apr; 54(1):19-28. PubMed ID: 11888654
[TBL] [Abstract][Full Text] [Related]
27. Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis.
Manichanh C; Grenot P; Gautheret-Dejean A; Debré P; Huraux JM; Agut H
Cytometry; 2000 Jun; 40(2):135-40. PubMed ID: 10805933
[TBL] [Abstract][Full Text] [Related]
28. In vitro evaluation of the anti-orf virus activity of alkoxyalkyl esters of CDV, cCDV and (S)-HPMPA.
Dal Pozzo F; Andrei G; Lebeau I; Beadle JR; Hostetler KY; De Clercq E; Snoeck R
Antiviral Res; 2007 Jul; 75(1):52-7. PubMed ID: 17184854
[TBL] [Abstract][Full Text] [Related]
29. New prodrugs of Adefovir and Cidofovir.
Tichý T; Andrei G; Dračínský M; Holý A; Balzarini J; Snoeck R; Krečmerová M
Bioorg Med Chem; 2011 Jun; 19(11):3527-39. PubMed ID: 21565516
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
De Clercq E
Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
[TBL] [Abstract][Full Text] [Related]
31. Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney.
Ciesla SL; Trahan J; Wan WB; Beadle JR; Aldern KA; Painter GR; Hostetler KY
Antiviral Res; 2003 Aug; 59(3):163-71. PubMed ID: 12927306
[TBL] [Abstract][Full Text] [Related]
32. The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus.
McMullan LK; Flint M; Dyall J; Albariño C; Olinger GG; Foster S; Sethna P; Hensley LE; Nichol ST; Lanier ER; Spiropoulou CF
Antiviral Res; 2016 Jan; 125():71-8. PubMed ID: 26526586
[TBL] [Abstract][Full Text] [Related]
33. [Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7].
Takahashi K
Nihon Rinsho; 1998 Jan; 56(1):140-4. PubMed ID: 9465679
[TBL] [Abstract][Full Text] [Related]
34. The UL97 protein kinase of human cytomegalovirus and homologues in other herpesviruses: impact on virus and host.
Michel D; Mertens T
Biochim Biophys Acta; 2004 Mar; 1697(1-2):169-80. PubMed ID: 15023359
[TBL] [Abstract][Full Text] [Related]
35. In vitro evaluation of current and novel antivirals in combination against human cytomegalovirus.
O'Brien MS; Markovich KC; Selleseth D; DeVita AV; Sethna P; Gentry BG
Antiviral Res; 2018 Oct; 158():255-263. PubMed ID: 30153445
[TBL] [Abstract][Full Text] [Related]
36. Micelle formulation of hexadecyloxypropyl-cidofovir (HDP-CDV) as an intravitreal long-lasting delivery system.
Ma F; Nan K; Lee S; Beadle JR; Hou H; Freeman WR; Hostetler KY; Cheng L
Eur J Pharm Biopharm; 2015 Jan; 89():271-9. PubMed ID: 25513956
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antiviral activities of methylenecyclopropane analogs with 6-alkoxy and 6-alkylthio substitutions that exhibit broad-spectrum antiviral activity against human herpesviruses.
Prichard MN; Williams JD; Komazin-Meredith G; Khan AR; Price NB; Jefferson GM; Harden EA; Hartline CB; Peet NP; Bowlin TL
Antimicrob Agents Chemother; 2013 Aug; 57(8):3518-27. PubMed ID: 23669381
[TBL] [Abstract][Full Text] [Related]
38. Antiviral and immunomodulatory activity of the metal chelator ethylenediaminedisuccinic acid against cytomegalovirus in vitro and in vivo.
Vogel JU; Michaelis M; Neyts J; Blaheta RA; Snoeck R; Andrei G; De Clercq E; Rabenau HF; Kreuter J; Cinatl J; Doerr HW
Antiviral Res; 2002 Jul; 55(1):179-88. PubMed ID: 12076762
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of nucleoside phosphonates and their analogs and prodrugs for inhibition of orthopoxvirus replication.
Keith KA; Hitchcock MJ; Lee WA; Holý A; Kern ER
Antimicrob Agents Chemother; 2003 Jul; 47(7):2193-8. PubMed ID: 12821467
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and antiviral evaluation of alkoxyalkyl esters of phosphonopropoxymethyl-guanine and phosphonopropoxymethyl-diaminopurine.
Ruiz JC; Aldern KA; Beadle JR; Hartline CB; Kern ER; Hostetler KY
Antivir Chem Chemother; 2006; 17(2):89-95. PubMed ID: 17042330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
